Last week, Health Affairs published three interviews [one-week free access] that I conducted with leading cancer oncologists. As Donald Kennedy, editor-in-chief of Science, and I wrote in an ...
A woman receiving an IV at the hospital. This article is part of an ongoing series on novel cancer advances, including immunotherapies such as CAR T therapy and checkpoint inhibitors. Future ...
LAFAYETTE, Ind. – There's a business in Lafayette that many people may not know about, though, that doesn't overshadow its important presence in the community. The Community Cancer Network, sometimes ...
TAMPA, Fla. — Elsa R. Flores, Ph.D., has been named Moffitt Cancer Center’s associate center director of Basic Science. In her new role, Flores will oversee the Basic Science Division, which includes ...
Somatic mutations have long been implicated in aging and disease, but their impact on fitness and function is difficult to assess. Here by analysing human cancer genomes we identify mutational ...
Morning Overview on MSN
1 protein block slowed cancer in mice, and it’s a promising target
Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases ...
Zyta Piegari has been "battling [cancer] for 28 years” and the Jamesport resident is now being treated for metastatic breast cancer. "My hair is growing a little," she said Tuesday as she awaited a ...
Professor Paul Workman was Chief Executive and President of The Institute of Cancer Research, London from 2014 to 2021. He is also Harrap Professor of Pharmacology and Therapeutics and has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results